Published in Hepatology on November 01, 2000
Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol (2010) 1.56
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci (2006) 1.33
An overview of occult hepatitis B virus infection. World J Gastroenterol (2011) 1.32
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines. Can J Gastroenterol (2012) 1.27
The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008) 1.22
Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China. PLoS One (2014) 0.98
Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression. PLoS One (2013) 0.89
Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy. J Clin Microbiol (2005) 0.88
Impact of comorbidities on the severity of chronic hepatitis B at presentation. World J Gastroenterol (2012) 0.88
Virological and clinical characteristics of hepatitis delta virus in South Asia. Virol J (2011) 0.88
Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China. World J Gastroenterol (2008) 0.87
Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis. Hepat Mon (2011) 0.85
Hepatitis B virus and hepatitis C virus dual infection. World J Gastroenterol (2014) 0.84
Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa. Virol J (2010) 0.83
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection. Eur J Clin Microbiol Infect Dis (2013) 0.82
An overview of triple infection with hepatitis B, C and D viruses. Virol J (2011) 0.82
Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical pictures. Hepat Mon (2013) 0.81
Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B. Hepatol Int (2008) 0.81
Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study. BMC Public Health (2011) 0.80
Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran. Hepat Mon (2013) 0.80
Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India. PLoS One (2016) 0.79
Role of occult hepatitis B virus infection in chronic hepatitis C. World J Gastroenterol (2015) 0.79
MiR-122 in hepatitis B virus and hepatitis C virus dual infection. World J Hepatol (2015) 0.78
Genetic variation of occult hepatitis B virus infection. World J Gastroenterol (2016) 0.75
Characteristics of hepatitis B infection in a sample of omani patients. Sultan Qaboos Univ Med J (2013) 0.75
Dual Infection with Hepatitis B and Epstein-Barr Virus Presenting with Severe Jaundice, Coagulopathy, and Hepatitis B Virus Chronicity Outcome. Am J Case Rep (2017) 0.75
Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection. PLoS One (2017) 0.75
MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin. Sci Rep (2016) 0.75
Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med (2001) 7.71
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol (1986) 6.20
Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology (1999) 5.79
Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet (1995) 4.71
Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet (1999) 3.86
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol (2000) 3.36
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Aliment Pharmacol Ther (2011) 3.10
Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis (2000) 2.98
Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ (1997) 2.70
Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy. J Hepatol (1996) 2.19
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol (1997) 1.98
Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology (1997) 1.96
Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis (2001) 1.89
Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet (1985) 1.75
Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight. Nature (2012) 1.56
Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group. J Hepatol (1997) 1.51
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol (2000) 1.48
Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone. Ital J Gastroenterol Hepatol (1999) 1.43
Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer (1999) 1.43
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome. Hepatol Int (2014) 1.41
Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. J Virol (1997) 1.35
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis (2006) 1.34
Single-particle structure determination by correlations of snapshot X-ray diffraction patterns. Nat Commun (2012) 1.30
[Intramedullary pinning of diaphyseal fractures of both forearm bones in adults: 46 cases]. Rev Chir Orthop Reparatrice Appar Mot (2008) 1.28
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology (2000) 1.17
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure. J Hepatol (1999) 1.14
HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol (2001) 1.14
Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis. Lancet (1980) 1.13
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol (2000) 1.12
Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update. Dig Liver Dis (2003) 1.09
Nanoplasma dynamics of single large xenon clusters irradiated with superintense x-ray pulses from the linac coherent light source free-electron laser. Phys Rev Lett (2012) 1.08
Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection (2009) 1.08
Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology (1999) 1.08
Diverticular disease as a risk factor for sigmoid colon adenomas. Dig Liver Dis (2002) 1.07
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib. Br J Cancer (2010) 1.06
Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology (1996) 1.05
Prevention of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA collaborating Group. J Viral Hepat (2000) 1.02
Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination. Vaccine (1993) 1.00
Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection (2004) 0.99
Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon. J Hepatol (1992) 0.98
Does HIV infection favor the sexual transmission of hepatitis C? Sex Transm Dis (2001) 0.98
Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe. Hepatology (1983) 0.98
Prevalence of Toxoplasma gondii antibodies among children and teenagers in Italy. Microbiologica (1991) 0.97
Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol (1999) 0.97
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C. Aliment Pharmacol Ther (2002) 0.97
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. J Viral Hepat (2012) 0.97
Seroepidemiology of pertussis in Italy. Rev Infect Dis (1992) 0.96
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. J Viral Hepat (2013) 0.95
Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol (1991) 0.95
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). Ital J Gastroenterol (1991) 0.95
Atopy, hygiene, and anthroposophic lifestyle. San Marino Study Group. Lancet (1999) 0.94
Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study. Hepatology (1994) 0.94
Decrease in HDV endemicity in Italy. J Hepatol (1997) 0.94
Femtosecond dark-field imaging with an X-ray free electron laser. Opt Express (2012) 0.93
Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol (1992) 0.92
Role of the specific T-cell response for clearance and control of hepatitis C virus. J Viral Hepat (1999) 0.92
Heterosexual transmission of hepatitis C in Italy. J Med Virol (1999) 0.91
Biosynthesis of mycophenolic acid. J Chem Soc Perkin 1 (1972) 0.90
Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol (1997) 0.90
[Intra- and postoperative fractures of the femur in total knee arthroplasty: risk factors in 32 cases]. Rev Chir Orthop Reparatrice Appar Mot (2006) 0.90
Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment. J Med Virol (2001) 0.89
The epidemiology of hepatitis delta infection in Italy. Promoting Group. J Hepatol (1992) 0.89
Clearance of hepatitis B virus DNA and pre-S surface antigens in patients with markers of acute viral replication. J Med Virol (1989) 0.89
Daclatasvir: the first of a new class of drugs targeted against hepatitis C virus NS5A. Curr Med Chem (2014) 0.88
Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol (2003) 0.88
Effects of HIV superinfection on HBV replication in a chronic HBsAg carrier with liver disease. J Hepatol (1988) 0.87
Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis. Liver (1989) 0.87
Serological survey of hepatitis B infection in Tanzania. Public Health (1994) 0.87
Surveillance of infectious diseases in the Italian military as pre-requisite for tailored vaccination programme. Vaccine (2001) 0.87
Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology (1998) 0.87
Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis. Infection (1975) 0.86
Alternative femoral bearing surface options for knee replacement in young patients. Knee (2004) 0.86
[Histochemical studies on the RNA content of the liver and pancreas of mice in ethionine poisoning]. Folia Med (Napoli) (1969) 0.86
Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study. J Viral Hepat (2006) 0.86
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. Infection (2012) 0.86
Hepatitis B virus clearance from serum and liver after acute hepatitis delta virus superinfection in chronic HBsAg carriers. J Med Virol (1990) 0.86
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. Infection (2013) 0.86
Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc. J Hepatol (1991) 0.86
Malacoplakia of the colon. Gastrointest Endosc (1995) 0.85
The use of molecular assays in the management of viral hepatitis. Dig Liver Dis (2008) 0.85
Acute viral hepatitis in childhood: etiology and evolution. J Pediatr Gastroenterol Nutr (1983) 0.85